FIELD: medicine; pharmacology.
SUBSTANCE: invention relates to the use of roluperidone. The following is disclosed: a method of treating or reducing amblyopia, comprising administering a therapeutically effective amount of roluperidone, that is, a compound (I), or a pharmaceutically acceptable salt or hydrate thereof.
EFFECT: use of roluperidone to treat negative symptoms and diseases, increase of neuroplasticity and promotion of neuroprotection.
19 cl, 4 dwg, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING BENZOATE COMPOUND AND TANNIC ACID FOR TREATMENT OF DISORDER OF CENTRAL NERVOUS SYSTEM | 2017 |
|
RU2756812C2 |
| ORGANIC COMPOUNDS | 2015 |
|
RU2709786C2 |
| USE OF MAVOGLURANT TO REDUCE COCAINE INTAKE OR TO PREVENT RECURRENT COCAINE INTAKE | 2018 |
|
RU2804834C2 |
| USE OF MAVOGLURANT TO REDUCE ALCOHOL USE OR TO PREVENT RECURRENT ALCOHOL USE | 2018 |
|
RU2806869C2 |
| INHIBITORS OF PHOSPHODIESTERASE 10 ENZYME | 2013 |
|
RU2667058C2 |
| 1,2,4-TRIAZOLO[4,3-A]PYRIDINE COMPOUNDS AND USE THEREOF AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS | 2015 |
|
RU2695651C2 |
| IMIDAZO[1,2-a]PYRIDINE DERIVATIVES AND THEIR APPLICATION AS POSITIVE ALLOSTERIC MODULATORS OF mGluR2 RECEPTORS | 2008 |
|
RU2492170C2 |
| ORGANIC COMPOUNDS | 2018 |
|
RU2777366C2 |
| AGONISTS OF NEUROTROPHIN RECEPTORS AND THEIR USE AS MEDICAMENTS | 2011 |
|
RU2606622C2 |
| METHOD OF POSTTRAUMATIC STRESS-INDUCED INJURY (PTSI) DIAGNOSTICS | 2007 |
|
RU2328977C2 |
